The Release of Human Pancreatic Polypeptide, Gastrin, Gastric Inhibitory Polypeptide, and Somatostatin in Celiac Disease Related to the Histological Appearance of Jejunal Mucosa before and 1 Year after Gluten Withdrawal

Abstract

Jejunal biopsies and the postprandial response of pancreatic polypeptide (PP), gastrin, gastric inhibitory polypeptide (GIP), and somatostatin have been examined in nine patients with celiac disease before and 1 year after gluten withdrawal. All presented initially with total villous atrophy of the jejunal mucosa. After gluten withdrawal five showed marked mucosal regeneration on light microscopy examination (responders) and four only moderate or no regeneration (nonresponders). Before treatment the celiac patients had enhanced gastrin response and normal PP response compared with normal controls. After gluten withdrawal the integrated gastrin release was reduced to normal in the responders (275 versus 114; p < 0.05) but remained elevated in the nonresponders (231 versus 204). Postprandial PP release was similar before and after treatment regardless of the degree of mucosal regeneration. In the responders the integrated release of GIP was increased (180 versus 241; p < 0.05), and the somatostatin release was enhanced (-2.6 versus 8.4; p < 0.05) after gluten withdrawal. We conclude that the postprandial release of GIP and somatostatin increases and that the release of gastrin decreases when the intestinal mucosa is regenerated in celiacs on a gluten-free diet. The release of PP after food is not influenced by mucosal regeneration.

Key-words:

• Celiac disease
• gastric inhibitory polypeptide
• gastrin
• pancreatic polypeptide
• somatostatin